University of South Florida, USA.
Taneja College of Pharmacy, Dean's Office, University of South Florida(USF), Tampa, FL, 33612, USA; Global Health, College of Public Health, (USF) and Faculty of Pharmacy and Public Health, Airlangga University, Surabaya, Indonesia.
Indian J Tuberc. 2021 Jan;68(1):114-118. doi: 10.1016/j.ijtb.2020.08.012. Epub 2020 Aug 27.
Tuberculosis (TB) is a highly infectious disease, and it has the highest global burden on India with 21% prevalence rate and 27% of patients who do not receive pertinent medical treatment. Although India spends 23 billion dollars annually towards medical expenses for TB, India still ranks among the top 2 countries with the highest incidence and prevalence rates with more than 300,000 deaths excluding the patients with HIV and TB calling for prompt consideration. India faces a great challenge socially and economically. They lack a uniform health care system, making it burdensome to use effective surveillance techniques for prevention of TB. Currently, India is working on resolving the issue meticulously through the web-based application program 'Nikshay' with other strategies like Revised National Tuberculosis Control Program (RNTCP) and World Health Organization's The End TB Strategy. India's cardinal goal is to make advanced diagnostic tools made available and public-private healthcare sector collaboration. India needs to focus more on primary prevention by effective policy formation and campaign which promote proper sanitation and vaccine administration while educating the layman.
结核病(TB)是一种高度传染性疾病,印度的负担最重,患病率为 21%,有 27%的患者未接受相关治疗。尽管印度每年在结核病医疗费用上支出 230 亿美元,但印度仍然是发病率和患病率最高的前 2 个国家之一,每年有超过 30 万人死亡,这还不包括艾滋病毒和结核病患者,因此需要紧急考虑。印度在社会和经济上面临着巨大的挑战。他们缺乏统一的医疗保健系统,因此难以使用有效的监测技术来预防结核病。目前,印度正在通过基于网络的应用程序“Nikshay”以及修订后的国家结核病控制计划(RNTCP)和世界卫生组织的《终结结核病战略》等其他策略,细致地解决这个问题。印度的首要目标是提供先进的诊断工具和公私医疗保健部门的合作。印度需要更加注重初级预防,制定有效的政策和开展宣传活动,促进卫生和疫苗接种,同时对公众进行教育。